Two International Drug Manufacturers Earn Warning Letters

Drug GMP Report
A A
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.

To View This Article:

Login

Subscribe To Drug GMP Report